Akèy › Neoplazmi pa tip istolojik
Etid klinik pou Neoplazmi pa tip istolojik ap rekrite nan Etazini
12 etid pou Neoplazmi pa tip istolojik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Atlanta, GA5 etid
- Boston, MA5 etid
- Los Angeles, CA4 etid
- Houston, TX4 etid
- Chicago, IL4 etid
- Baldwin Park, CA3 etid
- Dallas, TX3 etid
- Clifton, NJ3 etid
- Nashville, TN3 etid
- New York City, NY3 etid
- San Francisco, CA3 etid
- St. Louis, MO3 etid
- Tampa, FL3 etid
Pa eta
- Florid6 etid
- Georgia6 etid
- Illinois4 etid
- Kalifòni7 etid
- Massachusetts5 etid
- Michigan4 etid
- Missouri4 etid
- New Jersey5 etid
- New York3 etid
- Ohio4 etid
- Tennessee4 etid
- Texas6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07075185Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT06463665A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Aug 2, 2024 · NCT06271252Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.